Quartz·1 min read·easy
Bank of America is spending $250 million a year on weight loss drugs for employees
✦AI Summary
Bank of America reports that GLP-1 weight loss medications now constitute approximately 13% of its annual healthcare expenditure. The company spends roughly $250 million annually to cover these drugs for its employees.
CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in